World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
40
Citations
4854
World Ranking
8186
National Ranking
445

Overview

Annalisa Pinna is affiliated with the National Research Council (CNR) in Italy and conducts research primarily in the fields of Medicine and Neuroscience. Their work focuses extensively on Neurology and Cellular and Molecular Neuroscience, with additional contributions in Physiology, Molecular Biology, and Complementary and Alternative Medicine.

Their main topics of research cover Parkinson's Disease Mechanisms and Treatments, Neurological Disorders and Treatments, Adenosine and Purinergic Signaling, Nerve Injury and Regeneration, and Neuroscience and Neuropharmacology Research. They have also contributed to studies related to Ginkgo biloba and Cashew Applications, as well as Nanocomposite Films for Food Packaging.

Among their recent publications are:

  • Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson's disease, 2022, Frontiers in Pharmacology
  • Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson's Disease, 2020, Frontiers in Aging Neuroscience
  • Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage, 2021, International Journal of Molecular Sciences
  • Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist, 2021, Neuropharmacology
  • Serotonin 5-HT1A receptors and their interactions with adenosine A2A receptors in Parkinson's disease and dyskinesia, 2023, Neuropharmacology

Their work has been published across various journals, with frequent appearances in the International Journal of Molecular Sciences, Experimental Neurology, and Neuropharmacology. Other venues include Frontiers in Pharmacology and Frontiers in Aging Neuroscience.

They collaborate regularly with several co-authors, among whom are Micaela Morelli, Marcello Serra, Maria Antonietta Casu, Giulia Costa, and Pathik Parekh.

Best Publications

  • Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued

    Annalisa Pinna

  • Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.

    Sandro Fenu;Annalisa Pinna;Ennio Ongini;Micaela Morelli

  • Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

    Marie Therese Armentero;Annalisa Pinna;Sergi Ferré;José Luis Lanciego

  • Blockade of A2a Adenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1 Agonists in Dopamine-denervated Rats

    A. Pinna;G. Di Chiara;J. Wardas;M. Morelli

  • Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.

    M Morelli;S Fenu;A Pinna;G Di Chiara

  • Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.

    Annalisa Pinna;Sandro Fenu;Micaela Morelli

  • Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats

    Micaela Morelli;Sandro Fenu;Annalisa Pinna;Gaetano Di Chiara

  • Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: Comparison of the effects of different psychoactive drugs and relevance in drug-induced reward

    Nicola Simola;Sandro Fenu;Giulia Costa;Annalisa Pinna

  • New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists.

    Annalisa Pinna;Jadwiga Wardas;Nicola Simola;Micaela Morelli

  • Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6‐hydroxydopamine rat model of Parkinson's disease

    Annalisa Pinna;Silvia Pontis;Franco Borsini;Micaela Morelli

  • Novel investigational adenosine A2A receptor antagonists for Parkinson's disease.

    Annalisa Pinna

  • Modification of adenosine extracellular levels and adenosine A2A receptor mRNA by dopamine denervation

    Annalisa Pinna;Claudia Corsi;Anna Rosa Carta;Valentina Valentini

  • Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson’s Disease

    Sanjay Kasture;Silvia Pontis;Annalisa Pinna;Nicoletta Schintu

  • Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.

    Annarosa Carta;Elisabetta Tronci;A Pinna;Micaela Morelli

  • Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

    M. Morelli;A. Pinna;J. Wardas;G. Di Chiara

  • l-DOPA-treatment in primates disrupts the expression of A2A adenosine-CB1 cannabinoid-D2 dopamine receptor heteromers in the caudate nucleus

    Jordi Bonaventura;Alberto J. Rico;Estefanía Moreno;Salvador Sierra

  • l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies

    Annalisa Pinna;Jordi Bonaventura;Daniel Farré;Marta Sánchez

  • Involvement of Adenosine A2A Receptors in the Induction of C-Fos Expression by Clozapine and Haloperidol

    Annalisa Pinna;Jadwiga Wardas;Alberto Cozzolino;Micaela Morelli

  • Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.

    Micaela Morelli;A. Pinna

  • Late-onset Parkinsonism in NFκB/c-Rel-deficient mice.

    Cristina Baiguera;Manuela Alghisi;Annalisa Pinna;Annalisa Pinna;Arianna Bellucci

  • Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry.

    C. Cadoni;A. Pinna;G. Russi;S. Consolo

Frequent Co-Authors

Micaela Morelli
Micaela Morelli University of Cagliari
G. Di Chiara
G. Di Chiara University of Cagliari
José L. Lanciego
José L. Lanciego University of Navarra
Alessandro Usiello
Alessandro Usiello University of Campania "Luigi Vanvitelli"
Massimo Pasqualetti
Massimo Pasqualetti University of Pisa
Marina Pizzi
Marina Pizzi University of Brescia
Fabio Blandini
Fabio Blandini University of Pavia
Ikuo Tooyama
Ikuo Tooyama Shiga University of Medical Science
Gemma Navarro
Gemma Navarro University of Barcelona
Francesco Marrosu
Francesco Marrosu University of Cagliari

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Annalisa Pinna

Trending Scientists